CompoAtlas

PMK F07 Grapeseed Extract 100 mg - CVI

Natural health product licensed in Canada

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Extrait de pépins de Vitis Vinifera (raisin)

Source : Vitis vinifera - Graine

Potency : 95 % Polyphenols

Not specifiedNot calculated
Extrait de pépins de Vitis Vinifera (raisin)

Source : Vitis vinifera - Graine

Potency : 80 % Oligomeric proanthocyanidins

100 mgNot calculated

Non-medicinal ingredients

Glycérine, Gélatine, Huile de fève de soja, Dioxyde de silicium, Dioxyde de titane, Lécithine, Caramel, Cire d'abeille

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Capsule1 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

Source of antioxidants for the maintenance of good health. Helps to relieve symptoms related to non-complicated chronic venous insufficiency (CVI), such as sensation of swelling, heaviness and tingling of the legs.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Product record

Other names
Grapeseed Extract 100 mg
Licence holder
PMK Federal Regulatory Consultants Ltd.
NPN or DIN-HM
80042785
Status
Active licence
Licence date
12 June 2013
Revision date
7 October 2013
Form
Capsule, molle
Route of administration
Orale
Application type
Officinale

Source

Official Health Canada record, licence 80042785

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

Photograph the packaging

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “PMK F07 Grapeseed Extract 100 mg - CVI (PMK Federal Regulatory Consultants Ltd.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80042785-pmk-f07-grapeseed-extract-100-mg-cvi, updated 7 October 2013.

List recorded in 2013. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line